Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_assertion description "[Furthermore, treatment of ErbB2(KI) or human ERBB2-overexpressing tumor cells with a selective ?-catenin/CBP inhibitor significantly decreased proliferation and ErbB2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_assertion evidence source_evidence_literature NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_assertion SIO_000772 23720052 NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_assertion wasDerivedFrom befree-2016 NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_assertion wasGeneratedBy ECO_0000203 NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.
- befree-2016 importedOn "2016-02-19" NP1081794.RArV6E6irH1fQwF7jaepBRWRO8z0x8wxCy8pXtztlAtvU130_provenance.